14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CAPR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Capricor Therapeutics stock price down 1.69% on Thursday
(Updated on May 02, 2024)

Sell candidate since Apr 24, 2024 Gain 3.97% PDF

The Capricor Therapeutics stock price fell by -1.69% on the last day (Thursday, 2nd May 2024) from $5.33 to $5.24. During the last trading day the stock fluctuated 3.95% from a day low at $5.20 to a day high of $5.40. The price has fallen in 6 of the last 10 days but is still up by 3.76% over the past 2 weeks. Volume has increased on the last day by 39 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 210 thousand shares were bought and sold for approximately $1.10 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.07 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 38.26% during the next 3 months and, with a 90% probability hold a price between $7.01 and $10.95 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CAPR Signals & Forecast

There are few to no technical positive signals at the moment. The Capricor Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.25 and $6.08. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -26.15%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Capricor Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Capricor Therapeutics stock

Capricor Therapeutics finds support from accumulated volume at $5.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.205 between high and low, or 3.95%. For the last week, the stock has had daily average volatility of 5.80%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CAPR) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Capricor Therapeutics to open at $5.28, and during the day (based on 14 day Average True Range), to move between $4.83 and $5.65, which gives a possible trading interval of +/-$0.412 (+/-7.86%) up or down from last closing price. If Capricor Therapeutics takes out the full calculated possible swing range there will be an estimated 15.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.05 (3.63%) than the resistance at $5.80 (10.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Capricor Therapeutics will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.110. We will update the financials statements for Capricor Therapeutics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.41% in the first trading day after earnings release.

Is Capricor Therapeutics stock A Buy?

The Capricor Therapeutics stock holds several negative signals and despite the positive trend, we believe Capricor Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.872 Sell Candidate Unchanged

Predicted Opening Price for Capricor Therapeutics of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$5.28 ( 0.732%) $5.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CAPR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.48 4.64 %
R2 5.41 3.15 %
R1 5.36 2.23 %
Current price: 5.24
Support S1 5.20 -0.763 %
S2 5.15 -1.69 %
S3 5.07 -3.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.38 21.76 %
R2 5.89 12.40 %
R1 5.80 10.69 %
Current price 5.24
Support S1 5.05 -3.63%
S2 5.04 -3.82%
S3 4.82 -8.02%

FAQ

What is the symbol for Capricor Therapeutics Stock and on which exchange is it traded?
The symbol for Capricor Therapeutics is CAPR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Capricor Therapeutics Stock?
The Capricor Therapeutics stock holds several negative signals and despite the positive trend, we believe Capricor Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Capricor Therapeutics Stock?
Capricor Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Capricor Therapeutics Stock.

What's the current price of Capricor Therapeutics Stock?
As of the end of day on the May 02, 2024, the price of an Capricor Therapeutics (CAPR) share was $5.24.

What is the 52-week high and low for Capricor Therapeutics Stock?
The 52-week high for Capricor Therapeutics Stock is $8.22 and the 52-week low is $2.68.

What is the market capitalization of Capricor Therapeutics Stock?
As of the May 02, 2024, the market capitalization of Capricor Therapeutics is 165.076M.

When is the next earnings date for Capricor Therapeutics?
The upcoming earnings date for Capricor Therapeutics is May 09, 2024.
Click to get the best stock tips daily for free!

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT